EcoDrugPlus

Protein Kinase C Epsilon

Ensembl ID : ENSSTOG00000012596
Gene Symbol: PRKCE
3 Cross references
315 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSSTOG00000009567
Gene Symbol: PRKCH
4 Cross references
237 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSSTOG00000012738
Gene Symbol: PRKCG
4 Cross references
198 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSSTOG00000002794
Gene Symbol: PRKCI
3 Cross references
150 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSSTOG00000020180
Gene Symbol: PRKCQ
3 Cross references
203 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSSTOG00000012801
Gene Symbol: PRKCZ
3 Cross references
201 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSSTOG00000003873
Gene Symbol: PRKD1
4 Cross references
204 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSSTOG00000013902
Gene Symbol: PRKD3
3 Cross references
270 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Alpha

Ensembl ID : ENSSTOG00000002327
Gene Symbol: PRKACA
3 Cross references
283 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSSTOG00000003074
Gene Symbol: PRKACB
4 Cross references
297 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSSTOG00000009784
Gene Symbol: PRKDC
3 Cross references
184 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSSTOG00000011801
Gene Symbol: PPP3CA
4 Cross references
230 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).